Skip navigation

News

Business Weeklywww.businessweekly.co.uk

Cabume - www.cabume.co.uk

Cambridge Business Magazinehttp://www.cambridge-magazines.co.uk/Cambridge-Business-Magazine/

Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer

Research Triangle Park, NC and Cambridge, UK, September 8, 2017 -- Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, today announces the appointment of Dr Jamie Platt as Chief Operations Officer. More »
12 September 2017

Inivata Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Networ

This network will bring together global leaders in cancer care to unlock the potential of liquid biopsy to improve patient outcomes. More »
12 September 2017

Synpromics expands facilities to meet demand for revolutionary gene control technology

More »
11 September 2017

Cambridge Employers Line up to Meet Potential Candidates

Jobseekers have the opportunity to meet with a wide range of local employers at Cambridge Network's next Recruitment Event on Friday 29th September. Come along between 12pm and 4pm to learn about the latest vacancies from an impressive line-up of top Cambridge companies, including some of the region's most exciting and rapidly growing tech startups. More »
11 September 2017

Arecor Announces the Inaugural Formation of a Global Diabetes Scientific Advisory Board

Cambridge, UK., 08 September 2017: Arecor Ltd, the leading formulation technology company, focussed on developing superior biopharmaceuticals to improve the treatment of diabetes and other conditions, announces the inaugural formation of a Global Diabetes Scientific Advisory Board (“SAB”) to support the scientific, pre-clinical and clinical development of its proprietary superior diabetes products to better improve the quality of life of those living with diabetes. The SAB brings together three world-renowned scientists and endocrinologists from the US and EU with extensive expertise in the field of diabetes and related conditions. More »
11 September 2017

Cambridge Epigenetix Relocate to Chesterford Research Park to Accelerate Growth

Specialists in the discovery of epigenetic biomarkers and the development of clinical diagnostic assays take up residence in the Trinity Building More »
08 September 2017

Dr Sam Fazeli Joins Arecor as Non-Executive Director

Arecor Ltd, the leading formulation technology company, focussed on developing superior biopharmaceuticals to improve the treatment of diabetes and other conditions, is pleased to announce the appointment of Dr Sam Fazeli, as Non-Executive Director of the Company. More »
07 September 2017

Global Regulatory Services (GRS) Sets Down Roots in Sweden

It’s taken many months of planning and now it’s a reality. We are delighted, and very proud, to announce that GRS has established an office in Medicon Village, Lund. Bobby and Greer Deal, Directors of GRS, will be there on Monday 18th and Tuesday 19th September for the official launch. More »
05 September 2017

ReViral Initiates Phase 2a Study of RV521 for Treatment of Respiratory Syncytial Virus

Challenge trial will evaluate RV521 in approximately 70 volunteers More »
05 September 2017

First Subject Dosed in Phase 1 Clinical Study of Novel Selective Muscarinic M4 Agonist

Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers Index: 4565), announces that the first healthy subject has been dosed with the first-in-class, selective muscarinic M4 receptor agonist HTL0016878 in a Phase 1 clinical study. More »
04 September 2017

<< Previous   Page 2 of 36   Next >>